(VIANEWS) – Arcelor Mittal (MT), Installed Building Products (IBP), Healthcare Realty Trust Incorporated (HR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Arcelor Mittal (MT)

47.1% sales growth and 18.21% return on equity

ArcelorMittal and its affiliates own and operate steel mining and manufacturing facilities across Europe, North America, Asia and Africa.

Arcelor Mittal’s sales growth this year is anticipated to be 46.1% and a negative 11.5% for next year.

Year-on-year quarterly revenue growth grew by 76.2%, now sitting on 62.99B for the twelve trailing months.

Volume

Today’s last reported volume for Arcelor Mittal is 1691670 which is 48.89% below its average volume of 3309960.

Arcelor Mittal’s sales growth for the next quarter is 47.1%. The company’s growth estimates for the ongoing quarter and the next is 2536.8% and 1826.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.

Volatility

Arcelor Mittal’s last day, last week, and last month’s current intraday variation average was 0.04%, 0.63%, and 1.39%, respectively.

Arcelor Mittal’s highest amplitude of average volatility was 1.52% (day), 1.86% (last week), and 1.93% (last month), respectively.

Arcelor Mittal’s Stock Yearly Top and Bottom Value

Arcelor Mittal’s stock is valued at $25.37 at 06:22 EST, way below its 52-week high of $36.58 and way higher than its 52-week low of $20.50.

Arcelor Mittal’s Moving Average

Arcelor Mittal’s value is way below its 50-day moving average of $30.75 and way below its 200-day moving average of $30.93.

2. Installed Building Products (IBP)

21.9% sales growth and 41.4% return on equity

Installed Building Products, Inc. and its affiliates are involved in installing insulation, waterproofing, firestopping, fireproofing, garage door, rain gutters, blinds, windows, shower doors, closet shelves and mirrors throughout the United States.

Installed Building Products’s sales growth this year is expected to be 31.2% and a negative 1.4% for next year.

Year-on-year quarterly revenue growth grew by 38.7%, now sitting on 2.31B for the twelve trailing months.

Volume

Today’s last reported volume for Installed Building Products is 130066 which is 38.38% below its average volume of 211109.

Installed Building Products’s sales growth for the next quarter is 21.9%. The company’s growth estimates for the ongoing quarter and the next is 55.7% and 43%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.4%.

Volatility

Installed Building Products’s last day, last week, and last month’s current intraday variation average was 3.40%, 3.76%, and 2.38%, respectively.

Installed Building Products’s highest amplitude of average volatility was 4.49% (day), 4.17% (last week), and 3.63% (last month), respectively.

Installed Building Products’s Stock Yearly Top and Bottom Value

Installed Building Products’s stock is valued at $98.05 at 06:22 EST, way under its 52-week high of $141.43 and way above its 52-week low of $69.44.

Installed Building Products’s Moving Average

Installed Building Products’s value is above its 50-day moving average of $91.15 and below its 200-day moving average of $104.68.

3. Healthcare Realty Trust Incorporated (HR)

21.3% sales growth and 4.03% return on equity

Healthcare Realty Trust (Real Estate Investment Trust) is an investment trust for real estate that focuses on the acquisition, management, financing, and development of income-producing properties. It is associated with the provision of outpatient care services in the United States.

Healthcare Realty Trust Incorporated’s sales growth this year is anticipated to be 5.3% and 13% for next year.

Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 545.91M for the twelve trailing months.

Volume

Today’s last reported volume for Healthcare Realty Trust Incorporated is 3918980 which is 42.83% below its average volume of 6855930.

Healthcare Realty Trust Incorporated’s sales growth is a negative 0% for the current quarter and 21.3% for the next. The company’s growth estimates for the current quarter and the next is a negative 47.1% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.03%.

Volatility

Healthcare Realty Trust Incorporated’s last day, last week, and last month’s current intraday variation average was 2.01%, 1.05%, and 1.94%, respectively.

Healthcare Realty Trust Incorporated’s highest amplitude of average volatility was 3.32% (day), 2.62% (last week), and 3.39% (last month), respectively.

Healthcare Realty Trust Incorporated’s Stock Yearly Top and Bottom Value

Healthcare Realty Trust Incorporated’s stock is valued at $25.86 at 06:22 EST, way under its 52-week high of $34.83 and way higher than its 52-week low of $23.28.

Healthcare Realty Trust Incorporated’s Moving Average

Healthcare Realty Trust Incorporated’s worth is below its 50-day moving average of $27.76 and way under its 200-day moving average of $30.89.

4. H. B. Fuller Company (FUL)

15.2% sales growth and 10.58% return on equity

H.B. H.B.

H. B. Fuller Company’s sales growth this year is anticipated to be 17.2% and 3.7% for next year.

Year-on-year quarterly revenue growth grew by 20%, now sitting on 3.57B for the twelve trailing months.

Volume

Today’s last reported volume for H. B. Fuller Company is 31236 which is 90.32% below its average volume of 323006.

H. B. Fuller Company’s sales growth is a negative 0% for the current quarter and 15.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 34.6% and 18.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.58%.

Volatility

H. B. Fuller Company’s last day, last week, and last month’s current intraday variation average was 0.78%, 0.67%, and 0.86%, respectively.

H. B. Fuller Company’s highest amplitude of average volatility was 2.06% (day), 1.94% (last week), and 2.17% (last month), respectively.

H. B. Fuller Company’s Stock Yearly Top and Bottom Value

H. B. Fuller Company’s stock is valued at $64.38 at 06:22 EST, way under its 52-week high of $81.73 and way higher than its 52-week low of $57.36.

H. B. Fuller Company’s Moving Average

H. B. Fuller Company’s value is above its 50-day moving average of $63.77 and under its 200-day moving average of $69.65.

5. Harley (HOG)

13.5% sales growth and 25.85% return on equity

Harley-Davidson, Inc. produces and sells motorcycles for custom, cruiser, or touring purposes.

Harley’s sales growth this year is expected to be 6.9% and 7% for next year.

Year-on-year quarterly revenue growth declined by 4.1%, now sitting on 5.35B for the twelve trailing months.

Volume

Today’s last reported volume for Harley is 1046580 which is 35.04% below its average volume of 1611220.

Harley’s sales growth for the next quarter is 13.5%. The company’s growth estimates for the present quarter and the next is 33.3% and 14.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.85%.

Volatility

Harley’s last day, last week, and last month’s current intraday variation average was 1.43%, 1.59%, and 2.26%, respectively.

Harley’s highest amplitude of average volatility was 1.57% (day), 2.69% (last week), and 3.26% (last month), respectively.

Harley’s Stock Yearly Top and Bottom Value

Harley’s stock is valued at $37.68 at 06:22 EST, way under its 52-week high of $44.46 and way higher than its 52-week low of $29.80.

Harley’s Moving Average

Harley’s value is way above its 50-day moving average of $33.84 and higher than its 200-day moving average of $36.82.

6. Century Communities (CCS)

11% sales growth and 33.73% return on equity

Century Communities, Inc., along with its affiliates, is involved in design, development, building, marketing, sales, and maintenance of single-family detached and attached homes.

Century Communities’s sales growth this year is anticipated to be 10.4% and a negative 8.4% for next year.

Year-on-year quarterly revenue growth grew by 11.8%, now sitting on 4.35B for the twelve trailing months.

Volume

Today’s last reported volume for Century Communities is 199134 which is 35.9% below its average volume of 310687.

Century Communities’s sales growth for the next quarter is 11%. The company’s growth estimates for the current quarter and the next is 43.2% and 11.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.73%.

Volatility

Century Communities’s last day, last week, and last month’s current intraday variation average was 0.65%, 1.98%, and 1.65%, respectively.

Century Communities’s highest amplitude of average volatility was 3.61% (day), 3.90% (last week), and 4.14% (last month), respectively.

Century Communities’s Stock Yearly Top and Bottom Value

Century Communities’s stock is valued at $49.58 at 06:22 EST, way under its 52-week high of $86.07 and way above its 52-week low of $39.00.

Century Communities’s Moving Average

Century Communities’s value is higher than its 50-day moving average of $49.28 and way below its 200-day moving average of $60.68.

7. ViacomCBS (VIAC)

9.6% sales growth and 17.48% return on equity

ViacomCBS’s sales growth this year is expected to be 11.2% and 3.6% for next year.

Year-on-year quarterly revenue growth grew by 13.2%, now sitting on 27.46B for the twelve trailing months.

ViacomCBS’s sales growth is a negative 0% for the ongoing quarter and 9.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 16.5% and negative -30.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.48%.

Volatility

ViacomCBS’s last day, last week, and last month’s current intraday variation average was 9.41%, 7.70%, and 2.35%, respectively.

ViacomCBS’s highest amplitude of average volatility was 8.58% (day), 7.28% (last week), and 3.52% (last month), respectively.

ViacomCBS’s Stock Yearly Top and Bottom Value

ViacomCBS’s stock is valued at $0.00 at 06:22 EST, below its 52-week low of $28.90.

ViacomCBS’s Moving Average

ViacomCBS’s worth is below its 50-day moving average of $35.62 and below its 200-day moving average of $43.11.

8. United Therapeutics Corporation (UTHR)

7.1% sales growth and 12.94% return on equity

United Therapeutics Corporation is a biotechnology firm that develops and markets products for patients living with life-threatening and chronic diseases.

United Therapeutics Corporation’s sales growth this year is expected to be 10.7% and 11.5% for next year.

Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 1.69B for the twelve trailing months.

Volume

Today’s last reported volume for United Therapeutics Corporation is 98587 which is 80.33% below its average volume of 501237.

United Therapeutics Corporation’s sales growth for the next quarter is 7.1%. The company’s growth estimates for the present quarter and the next is 10.7% and 22.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.94%.

Volatility

United Therapeutics Corporation’s last day, last week, and last month’s current intraday variation average was 0.47%, 0.75%, and 1.02%, respectively.

United Therapeutics Corporation’s highest amplitude of average volatility was 2.05% (day), 2.72% (last week), and 3.18% (last month), respectively.

United Therapeutics Corporation’s Stock Yearly Top and Bottom Value

United Therapeutics Corporation’s stock is valued at $229.84 at 06:22 EST, below its 52-week high of $245.48 and way higher than its 52-week low of $158.38.

United Therapeutics Corporation’s Moving Average

United Therapeutics Corporation’s value is above its 50-day moving average of $227.91 and way higher than its 200-day moving average of $200.73.

LEAVE A REPLY

Please enter your comment!
Please enter your name here